Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29787366

CCOC(=O)c1ccc(NC(=O)CN)cc1.Cl

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 3/20 0.65
TSHR P16473 1/20 0.70
RAB9A P51151 5/20 0.68
SMN1; SMN2 Q16637 5/20 0.62
MEN1 O00255 5/20 0.62
KMT2A Q03164 5/20 0.62
MAPT P10636 4/20 0.62
ALDH1A1 P00352 3/20 0.62
KDM4E B2RXH2 1/20 0.62
MAPK1 P28482 1/20 0.62
NPC1 O15118 2/20 0.60
CASP3 P42574 1/20 0.60
TRPV1 Q8NER1 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
TP53 P04637 1/20 0.60
POLB P06746 1/20 0.60
CA12 O43570 1/20 0.58
CA9 Q16790 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141724 0.98 TSHR (0.72) TSHRRAB9AGAASMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL5194020 0.88 GAA (0.70) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL802338 0.86 GAA (0.72) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL5947516 0.86 TSHR (0.77) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL9671985 0.85 TSHR (0.77) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL2840873 0.84 TSHR (0.74) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL2840870 0.84 TSHR (0.74) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL656903 0.83 MEN1 (0.77) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL1411400 0.83 RAB9A (0.76) TSHRRAB9AGAASMN1; SMN2MEN1
SCHEMBL6690396 0.83 TSHR (0.72) TSHRRAB9AGAASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119432675-A Acetobacter ganii JK-23 and application thereof in antioxidation and anti-inflammatory 江苏农林职业技术学院 2025-02-14 CN claimed
CN-115286866-B Elastic material, electroosmosis plate frame and electroosmosis partition plate 厦门安力克膜科技有限公司 2024-09-10 CN claimed
CN-117645953-A Lactobacillus reuteri JK23 and preparation method and application of freeze-dried powder thereof 江苏新申奥生物科技有限公司 2024-03-05 CN claimed
CN-116622149-A Full-biodegradation low-pressure calabash film and preparation method thereof 福建省铨丰环保科技有限公司 2023-08-22 CN claimed
CN-116554591-A Biodegradable buffer gas column material master batch and preparation method thereof 福建省铨丰环保科技有限公司 2023-08-08 CN claimed
CN-107450482-B Automatic control system for rubber unloading process of natural rubber drying production line 海南大学 2023-02-24 CN claimed
CN-115286866-A Elastic material, electrodialysis plate frame and electrodialysis partition plate 厦门安力克膜科技有限公司 2022-11-04 CN claimed
US-20250325569-A1 COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2025-10-23 US disclosed
US-20250253703-A1 METHOD FOR DIRECTLY CHARGING BATTERY, APPARATUS, SYSTEM AND DEVICE FOR DIRECTLY CHARGING BATTERY BASED ON PHOTOVOLTAIC PANELS BEIJING LEI RAN CYCLE TECHNOLOGY CO., LTD (CN) 2025-08-07 US disclosed
CN-120156167-A Weather-resistant metal pearlescent film and preparation method thereof 江苏新光镭射包装材料股份有限公司 2025-06-17 CN disclosed
CN-119432675-A Acetobacter ganii JK-23 and application thereof in antioxidation and anti-inflammatory 江苏农林职业技术学院 2025-02-14 CN disclosed
CN-119432675-A Acetobacter ganii JK-23 and application thereof in antioxidation and anti-inflammatory 江苏农林职业技术学院 2025-02-14 CN disclosed
CN-119432675-A Acetobacter ganii JK-23 and application thereof in antioxidation and anti-inflammatory 江苏农林职业技术学院 2025-02-14 CN disclosed
CN-116554591-A Biodegradable buffer gas column material master batch and preparation method thereof 福建省铨丰环保科技有限公司 2023-08-08 CN disclosed
CN-107450482-B Automatic control system for rubber unloading process of natural rubber drying production line 海南大学 2023-02-24 CN disclosed
CN-115425732-A Direct battery charging method, device, system and equipment based on photovoltaic panel 北京磊然循环科技有限公司 2022-12-02 CN disclosed
CN-115286866-A Elastic material, electrodialysis plate frame and electrodialysis partition plate 厦门安力克膜科技有限公司 2022-11-04 CN disclosed
CN-111432635-B Non-human animals with engineered immunoglobulin lambda light chains and uses of the non-human animals 瑞泽恩制药公司 2022-10-21 CN disclosed
CN-115117995-A Direct battery charging method, device, system and equipment based on photovoltaic panel 北京磊然循环科技有限公司 2022-09-27 CN disclosed
US-11414557-B2 Active-energy-ray-polymerizable initiator, active-energy-ray-polymerizable composition, active-energy-ray-polymerizable ink, ink storage container, image forming method, and image forming apparatus RICOH COMPANY, LTD. (JP) 2022-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11414557-B2 Active-energy-ray-polymerizable initiator, active-energy-ray-polymerizable composition, active-energy-ray-polymerizable ink, ink storage container, image forming method, and image forming apparatus ILK, NAP1L4, ORC3 GAA 4198/4885TSHR 4775/4885RAB9A 3283/4885
US-20250325569-A1 COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF PGLS, PLA2G2C, PPA1 GAA 306/4885TSHR 4553/4885RAB9A 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.